Join Now

The voice of utah’s life sciences community

BioUtah is the common voice and flag bearer for Utah’s life sciences industry comprised of medical devices, pharmaceutical, diagnostics, and biotechnology. Together we form an ecosystem that fosters collaboration, promotes innovation and delivers technology that saves lives.

Learn More

Medical Device

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

March 13-14, 2025

Salt Lake City | Snowbird

Learn More

2024 Utah Life Sciences Award Recipients

Lifetime Achievement
Dr. Wm. Dean Wallace

Innovation Impact
Blackrock Neurotech

Entrepreneur of the Year
Jay Muse

Executive of the Year
Bradford Brown

Friend of Industry
Vic Hockett

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

April 17, 2025
BioUtah News
Congresssional Staffer Tours

Congresssional Staffer Tours

April 17, 2025
BioUtah News
Nelson Labs Celebrates 40 Years of Excellence in Science and Service

Nelson Labs Celebrates 40 Years of Excellence in Science and Service

April 10, 2025
BioUtah News
Peer-Reviewed Article Reporting DiscGenics’ Cell Therapy Phase I/II Study Results Receives International Journal of Spine Surgery Best Paper Award

Salt Lake City, UT – April 9, 2025 – DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced that the double-blind, peer-reviewed article, “Allogeneic Disc Progenitor Cells Safely Increase Disc Volume and Improve Pain, Disability, and Quality of Life in Patients With Lumbar Disc Degeneration—Results […]

April 10, 2025
BioUtah News
BREAKING GROUND ON COMPREHENSIVE CANCER CENTER IN VINEYARD

Huntsman Cancer Institute at the University of Utah (the U) broke ground on its second Comprehensive Cancer Center on Tuesday, April 8, advancing construction of a new facility wholly dedicated to delivering prevention, hope, and healing to cancer patients. Situated in Vineyard, in the heart of Utah County, the Huntsman Cancer Institute site will reduce […]

April 10, 2025
BioUtah News
The ‘Father of Modern Food and Drug Law,’ Peter Hutt, Joins EVŌQ Nano Board of Directors

Hutt Brings Decades of Regulatory Insight to Help Advance Nanoparticle Technology Platform  SALT LAKE CITY, Utah (April 9, 2025) — EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life, material, and textile science industries, today announced the appointment of Peter Barton Hutt, former FDA Chief Counsel, to its board of directors. Widely […]

April 10, 2025
BioUtah News
Recursion and Enamine Release New AI-Enabled Targeted Compound Libraries

Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced the generation of screening libraries leveraging tools within its AI/ML platform, the Recursion OS, with Enamine’s REAL Space, the world’s largest source of make-on-demand small […]

April 10, 2025
BioUtah News
Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas

REC-3565 is a potential best-in-class MALT1 inhibitor for multiple hematology indications, designed to reduce the risk of hyperbilirubinemia, a common side effect of other MALT1 inhibitorsSalt Lake City, UT, April 08, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that the first patient has […]

April 10, 2025
Policy News
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer

SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian Donnelly as chief commercial officer (CCO), effective May 1, 2025. A strategic, results-oriented leader with more than 20 years of experience in healthcare, diagnostics, and medical […]

From Here to There

See how BioUtah, the only trade association dedicated solely to Utah’s Life Sciences industry, can help your business grow.


Networking

Advocacy

Investment

Workforce Development

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors